ATTO: Redmile Group Buys $3.4M in Attovia Amid Cluster Buying
Attovia Therapeutics, Inc. (NASDAQ: ATTO) is showing a fresh cluster of insider buying, with Redmile Group, LLC — a 10%+ owner of the company — disclosing an open-market purchase of 200,000 shares at $17.00 per share on August 6, 2026. The transaction, filed on Form 4, totaled $3,400,000 and brings Redmile Group’s directly held stake … Read more